Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer
Clinical trial NCT02664103 · COMPLETED
Trial details
- NCT number
- NCT02664103
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-23
- Primary completion
- 2017-11-06
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.